Buzz Pocket

Monday, August 16, 2021

Why Dynamics of Critical Care Devices Market Is Changing Drastically? What If History Is Any Guide?

The coronavirus outbreak has influenced the critical care devices industry fairly and positively. Expanded usage of critical care devices is expected to fuel the demand for COVID-19 care during the forecast era. Markets are projected to provide investors with more growth prospects over time. Leading players of the market are predicted to unlock vibrant opportunities for the growth of the market in the forthcoming years by taking various initiatives.

The latest research report on the global critical care devices market by Research Dive reflects the influence of COVID-19 pandemic on the present and expected growth of the global market. This report is professional and comprehensive research formulated by specialists by evaluating top driving factors, major regional market situations, opportunities & future scope, and trends & developments in the market during the COVID-19 catastrophe.

Highlights of the Report:

The global critical care devices market has witnessed remarkable growth in the previous years. The sudden outbreak of COVID-19 has impacted the market, bringing even more chances of growth. As per the report, the global critical care devices industry is expected to register a revenue of $41.5 million by 2027, at a growth rate of 3.2% during the forthcoming years. In the current situation, the market has garnered $33.3 million in 2020, owing to the increasing demand for critical care devices across the healthcare industry.

Factors Driving the Market Growth amid COVID-19 Pandemic:

As per our analyst estimates, the growth of the global critical care devices industry is majorly attributed to the significantly rising adoption of critical care devices system by the healthcare industry. However, high costs to obstructing the growth of the critical care devices industry.

The report discloses the real-time CAGR recorded by the market during the pandemic. According to the report, the critical care devices market has earned a CAGR of 3.2% during the last few months of the crisis, while the pre-COVID-19 estimation was only 3%. The reason behind this growth is the growing necessity of growing adoption of critical care devices in the healthcare industry owing to longer life cycles.

Current COVID-19 Impacted Scenario of the Market:

The leading players of the market are focused on developing new, innovative strategies to sustain market growth. To drive the demand during the pandemic, innovation in critical care instruments that are used in surgical procedures, and an increase in intensive care units has allowed healthcare institutions to provide better healthcare services for the patient. It is expected that a lack of skilled labor to operate such tools would hamper the demand in the forecast period.

Future Scope of the Market:

According to the report, the global critical care devices market is projected to maintain sustainable growth post the pandemic.

New entrants and leading players including GE Healthcare, Cardinal Health, Breas Medical, Boston Scientific Corporation, Biometrix, Asahi Kasei Corporation, Airon Corporation, Air Liquide Medical Systems, Biometrix and Avanos Medical, Inc, among others are expected to bring in some newer innovative advances and rewarding opportunities for the market in next few years. The report summarizes the following aspects of all key players: business overview – financial performance, product portfolio, recent strategic moves & developments, SWOT analysis.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Toll Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

COVID-19 Impact: What Challenges Organ Care System Market May See In Next 5 Years?

The COVID-19 outbreak has helped the global organ care system market to grow at a positive rate. The manufactures of the industry are investing more in R&D activities to grow exponentially during the forecast period.

The COVID-19 pandemic has positively impacted the global Organ care system (OCS) for liver market and a slight increase in the growth rate is observed from the previous predictions. As per new Research Dive published report, the global OCS for liver market is anticipated to grow at a CAGR of 9.3% by 2026, generating a revenue of $42.7 million in the period of forecast from 2019 to 2026. To better understand the pandemic effect on the global market, the report includes comprehensive analysis on growth opportunities, restraints, drivers, vital segments, and strategies adopted by major market players.

Highlights of the Report

As per our analysts, the rising cases of end stage liver failure coupled with the increasing number of liver transplants carried out all over the world is a significant factor impelling the growth of global OCS for liver market. The projected market size for the OCS for liver industry prior to COVID-19 chaos was $24.8 million in 2020 and this number is predicted to increase up to $25.2 million post-coronavirus pandemic. The growing prevalence of chronic diseases in liver and the rising consumption of alcohol are other factors responsible for the market growth. Conversely, the unavailability of donors and the high costs associated for treatment of liver disease are likely to restrict the market growth during the forecast period.

Implementing Several Strategies to Grow Exponentially Pandemic Crisis

The leading players of the OCS for liver industry OrganOx Limited, TransMedics Inc., Preservation Solution Inc., Organ Assist B.V., Organ Transport System Inc., Preservation Solution Inc., Bridge to Life Ltd., Paragonix Technologies Inc., Water Medical System LLC, Organ Recovery Systems Inc., and XVIVO Perfusion AB. These players are investing more in research and development activities to grow exponentially and maintain a strong market position.

For instance, Transmedics along with J.P Morgan and Morgan Stanley initiated offering successive trials showing decreased complications in transplant of liver.

Moreover, in January 2019, the UK national institute for health and care approved the liver perfusion machine of OrganOx. This technology is addressed as a ‘game changer’ by many industry experts.

Global Industry to Witness Impressive Growth Post-COVID-19 Chaos

Research Dive states that the global OCS for liver market is anticipated to experience a robust growth post-coronavirus pandemic. In order to meet the demand of supply, the manufacturers of the industry are taking efforts t advance and improve the organ care systems. Moreover, the rising demand for OCS and the growing cases of liver chronic diseases are factors predicted to propel the market growth after COVID-19 pandemic.

Contact Us:

Medical Tourism Market Update - Increasing Investment Is Expected To Boost Market Growth in 2027

The COVID-19 crisis has affected the global medical tourism market in a negative way. The governments are taking initiatives to help patients seek healthcare treatment and the market is likely to recover by Q1/Q2 of 2022.

The COVID-19 pandemic has hugely impacted the global medical tourism market and a slight downfall is witnessed in the growth rate as compared to the former predictions. As per new Research Dive published report, the global medical tourism market is anticipated to rise at a CAGR of 11.7% by 2026, generating a revenue of $142.2 billion in the period of forecast from 2019 to 2026. While there is a decrease in the growth rate due to the COVID-19 outbreak, the market is likely to recover by Q1/Q2 of 2022.

Highlights of the Report

As per our analysts, the increasing interests amongst people coupled with technological advancements in healthcare treatment is a significant factor impelling the growth of global medical tourism market.

The projected market size for the medical tourism industry prior to COVID-19 chaos was $73.7 billion in 2020 and this number is expected to drop down to $44.2 billion post-coronavirus pandemic. The risk associated with travel after surgery, language barrier, and quality of staff members will hinder the market growth in the coming years.

Conversely, the rising interests of people towards better quality healthcare coupled with advanced technology and low cost will propel the demand for medical tourism during the forecast period.

Sustaining in the Pandemic Situation

A number of countries all over the world are inviting well known medical specialists Cleveland Clinic, Mayo Clinic, and Harvard Medical International by investing more to develop medical tourism facilities.

Furthermore, other countries are adopting diverse strategies in order to fuel the growth of medical tourism market. For instance, India launched visa facilities for foreigners namely, ‘M-visa,’ to allow foreigners to enter the country for healthcare treatment.

In addition, the doctors in Singapore are treating people to maximum of three diverse locations, which is based on the guidelines of Ministry of Health (MOH) to stop the spread of COVID-19 virus.

The leading players of the medical tourism industry include Anadolu Medical Centre, Shouldice Hospital, Clemenceau Medical Centre, Prince Court Medical Centre, Gleneagles Global Hospitals Group, and Bangkok Hospital.

Global Industry to Witness Significant Growth Post-Coronavirus Chaos

Research Dive states that the global medical tourism market is projected to witness considerable growth post-COVID-19 pandemic. There are various benefits associated with medical travel such as availability of better-quality medical treatment, accessibility of medication, and low costs, which will surge the demand for medical tourism during the forecast period.

Moreover, various countries such as Thailand, India, and Singapore are gaining importance due to availability of low-cost healthcare treatment, which is predicted to propel the market growth after COVID-19 pandemic.

Contact Us:

Industry Dynamics: What Makes Antiviral Therapy Market Outperforming Its Substitutes Despite COVID-19 Chaos?

The rise of COVID-19 pandemic has positively impacted the global antiviral therapy market in 2020. Rising research & development and advances in the production of antiviral drugs is fueling the growth of the market during COVID-19 crisis.

A new report by Research Dive deliberates the impact of COVID-19 on the present and future growth of the global antiviral therapy market. This report is formulated by market professionals by considering all the important factors such as regional market conditions, current trends & developments, market drivers and restraints, and size & scope of the market. This report is a valuable source of information and guidance for professionals involved in this market.

Key Highlights of the Report:

The COVID-19 pandemic has imposed a positive impact on the global market for antiviral therapy. As per the report, the global antiviral therapy market was valued at $48.1 million in 2018 and is estimated to gather $79.8 million by soaring at a growth rate of 6.7% by 2026. In the present condition, the market has collected a revenue of $54.7 million owing to the growing demand for antiviral drugs for treating COVID-19 patients.

Factors Boosting the Market Growth amidst Covid-19 Pandemic:

As per the report, factors such as growing investments in R&D of antiviral therapies, effectiveness of antiviral drugs to treat COVID-19 infection, and rising interest of pharmaceutical firms in the manufacture of antiviral drugs are fueling the growth of the global antiviral therapy market. Furthermore, increasing demand for antiviral drugs from numerous countries is boosting the growth of the global industry.

Current Market Situation Due to COVID-19:

Some of the foremost companies operating in this market are working on the development of more advanced medicines. Moreover, some top players are entering into partnerships and collaborations to expand their business in the course of the crisis period. For example, in May 2020, Cipla, a leading multinational pharmaceutical company has collaborated with Gilead Sciences for the production and supply of the investigational drugs used in the treatment of COVID-19 patients. The company has also joined hands with the Hyderabad-based Indian Institute of Chemical Technology (IICT) to manufacture anti-viral drugs for treating COVID-19 infection.

Furthermore, in April 2020, Ennaid Therapeutics, LLC, a leading biopharmaceutical venture has declared that they are advancing the manufacture of ENU200 for the treatment of COVID-19 affected patients. Such initiatives undertaken by key players are leading to the growth of the global antiviral therapy market.

Future Scope of the Market:

As per analysts, the global antiviral therapy industry is projected to experience incessant growth post-COVID-19 crisis owing to the predicted rise in the demand for antiviral drugs. New entrants and some of the foremost players including AbbVie Inc., Inc., Johnson & Johnson Services, GlaxoSmithKline plc., Gilead Sciences, Inc., Merck & Co., Inc., Informa plc., Cipla Inc., Dr. Reddy’s Laboratories Ltd., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., and others are likely to come up with ground-breaking developments and unlock profitable opportunities for the growth of the market growth in the coming future.

Contact Us:

COVID-19 Impact: Which Are the Key Players Evolving In the Growth of Assisted Reproductive Technology Market?

The worldwide spread of COVID-19 has positively impacted the global assisted reproductive technology market. This is mainly due to supportive government policies and the strategic steps taken by major market players in the pandemic crisis. For instance, in June 2020, SART launched its fertility expert’s podcast series. Furthermore, the global market is expected to observe substantial growth even after the pandemic owing to the growing adoption of R&D and growing awareness amongst people regarding assisted reproductive technology.

The global assisted reproductive technology market is likely to experience an increase in the growth rate during the COVID-19 pandemic. As per a new report added by Research Dive, the global assisted reproductive technology market is anticipated to reach up to $56.3 billion during the forecast period from 2019 to 2026. Comprehensive analysis on drivers, challenges, growth opportunities, major segments, and key strategies executed by major market players are provided in the report for better understanding of the pandemic effect on the global market.

Highlights of the Report-

– The expected CAGR of the assisted reproductive technology market before COVID-19 pandemic was 10.3% during the forecast period.

– The CAGR of the global market after the pandemic crisis is projected to grow at a CAGR of 10.7% by 2027.

– In 2020, the expected market size of the assisted reproductive technology market before COVID-19 pandemic was $27.0 billion.

– Due to COVID-19 pandemic, the market size of the global market is expected to reach up to $27.6 billion in 2020.

Key Features of the Market

Our analysts stated that the supportive government policies and rise in number of government approvals for assisted reproductive technology for infertile couples’ treatment are the major factors expected for progressive market growth. For instance, in February 2020, the Indian government passed ‘assisted reproductive technology (ART) regulation bill’ amidst the COVID-19 pandemic. The bill is approved by the government to regulate the ART clinics with an aim to offer ‘safe and ethical’ reproductive procedures to nearly 27 billion infertile couples in the country.

Furthermore, many institutions and organizations are coming forward their strategic steps in the pandemic crisis with an objective to help infertile couples. For instance, in June 2020, Society for assisted reproductive technology (SART) announced the launch of its fertility experts’ podcast series. Multiple topics regarding the fertility treatment are addressed in the podcast. The aim of SART is to offer patient-friendly education in order to help them in understanding fertility problems and treatment options. These initiatives by various organizations are predicted to create huge awareness amongst individuals, which is projected to drive the growth of the global assisted reproductive technology market during COVID-19 crisis.

Prominent Players of the Industry

The major players operating in the global assisted reproductive technology market include Merck KGaA, Nidacon International AB, Cook, California Cryobank, FUJIFILM Irvine Scientific, IVFtech ApS, CooperSurgical, Inc., Hamilton Thorne, Inc., Thermo Fisher Scientific Inc., and Ferring Pharmaceuticals. The report summarizes various aspects of all these key players including financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis.

Post-Pandemic Scenario

As per the report, the global assisted reproductive technology market is expected to witness a progressive growth even after the COVID-19 pandemic. The growing adoption of R&D and innovations and the increase in number of patients suffering from childlessness and infertility disorders are expected to boost the growth of the global market during the forecast period. Besides, the growing success rate of assisted reproductive technology is other factor likely to propel the market growth after COVID-19 pandemic. For instance, according to the statistics provided by SART, more than 74,000 babies were born in 2018 with the help of using assisted reproductive technology.

Contact Us:

Why Dynamics of Laboratory Temperature Control Units Market Is Changing Drastically? What If History Is Any Guide?

The worldwide spread of COVID-19 has positively impacted the global laboratory temperature control units market. This is mainly because various market players are taking initiatives to such as new innovations and novel technologies to fight the challenges created by COVID-19 outbreak. Furthermore, the global market is expected to observe substantial growth even after the pandemic owing to increasing adoption of laboratory temperature control units in the various industries such as pharmaceuticals, food & beverages, and cosmetics.

The global laboratory temperature control units market is likely to experience an increase in the growth rate during the COVID-19 pandemic. As per a new report added by Research Dive, the global laboratory temperature control units market is anticipated to reach up to $833.83 million during the forecast period from 2019 to 2026. Comprehensive analysis on drivers, challenges, growth opportunities, major segments, and key strategies executed by major market players are provided in the report for better understanding of the pandemic effect on the global market.

Highlights of the Report

– The expected CAGR of the laboratory temperature control units market before COVID-19 pandemic was 5.3% during the forecast period.

– The estimated CAGR of the global market after the pandemic crisis is projected to grow at a CAGR of 5.5% by 2027.

– In 2020, the expected market size of the laboratory temperature control units market before COVID-19 pandemic was $562.9 million.

– Due to COVID-19 pandemic, the market size of the global market is expected to reach up to $571.4 million in 2020.

Key Features of the Market

Our analysts stated that the key players operating in the global market are taking initiatives to fight the challenges created during the COVID-19 pandemic, which is expected to be the major factor for the progressive market growth. For instance, in April 2020, German-based temperature controller manufacturers, Peter Huber Kältemaschinenbau AG, introduced a high precision ‘temperature control technology’ for researchers to usage in manufacturing of coronavirus test reagents.

Furthermore, many institutions and organizations are coming forward with new innovations to sustain in the pandemic. For instance, a significant leader in temperature control technologies, Julabo is developing and shipping temperature controllers to other companies in the pandemic crisis. These devices help biotech or pharmaceutical companies to control the temperature of their reactors required for the manufacturing of COVID-19 vaccines.

Prominent Players of the Industry

The major players operating in the global laboratory temperature control units market include IKA-Werke Staufen GmbH&Co.KG, Thermo Fisher Scientific Inc., PolyScience, Peter Huber Kältemaschinenbau AG, LAUDA, JULABO GmbH., Delta Electronics, inc., Bio-Rad Laboratories, Inc., and BIOLINE GLOBAL. The report summarizes various aspects of all these key players including financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis.

Post-Pandemic Scenario

As per the report, the global laboratory temperature control units market is expected to witness a progressive growth even after the COVID-19 pandemic. The growing adoption of laboratory temperature control units in various industries including pharmaceuticals, cosmetics, and food & beverages is estimated to drive the growth of the global market during the forecast period. Besides, the increasing focus of market players on innovative product development and product launches is expected to boost the market growth after COVID-19 pandemic. For instance, Briskheat, in November 2019, announced the launch of the LYNX temperature control system having the capability to control up to 1,024 zones.

Contact Us:

The COVID-19 Fallout: Enzymes Market in 2020 - What Does the Year Ahead Hold?

The outbreak of COVID-19 has a marginal impact on the enzyme market. The sustainability of this market is majorly attributed to the extensively rising demand in bio-detergent, biofuels, pulp and paper manufacturing processes, rubber manufacturing, and molecular biology. Due to the COVID-19 pandemic, the majority of the ventures which are operating in the manufacturing of enzymes are currently working on the production sanitizers to fight against COVID-19. For example, in April 2020, BASF, the largest enzyme manufactures company, has started production of hand sanitizer to support the fight against COVID-19 in New York and New Jersey. This may cause a considerable decline in the growth of the global enzyme market, in the global market. However, as per the publication of Amway, they will increase the production and supply of immunity-building products in view of the COVID-19 pandemic crisis. These factors may drive the demand for enzymes in the global market, during the forecast period. The company such as AB enzymes has taken strategic decisions to follow the World Health Organization (WHO) and local government advice regarding the global network of sites.

AB enzymes safeguarding the health employees along with continuing to supply solutions for customers’ applications. By utilizing such strategies, the enzyme ventures across the world are preparing for the post-pandemic impact. During this unprecedented situation, we are helping our clients in understanding the impact of COVID19 on the Global Enzyme.

As per a new publication of Research Dive, the global enzyme is set to generate revenue of $17,875.7 million by 2026, at a CAGR of 9.4% during the forecast period.

The segmentation of the market has been done on the basis of source, product, application, and region. The report provides in-depth insights on drivers, opportunities, restraints, vital segments, and leading industry players of the market. As per our analyst estimates, enzymes have functional versatility along with it has wide applications in multiple fields is key factors propelling the enzyme market growth. Contrary to this, safety and handling issues regarding enzymes are projected to hamper the growth of the global enzyme market, during the period of forecast.

Micro-organisms for the global enzyme market will have the fastest growth During 2020-27

On the basis of source, the global market for an enzyme is classified into micro-organisms, Plants, Animals. The micro-organisms market is valued at $7,565.0 million revenue in 2018 and is expected to grow at 9.6% CAGR by the end of 2026. The growth of the micro-organisms segment is prominently driven by the significant capability of micro-organisms to produce enzymes with a wider range of applications.

Lipase will register substantial market growth during the period of forecast

Based on the product the enzyme is broadly categorized into polymerases & nucleases, proteases, carbohydrase, lipases, and others, The market size for lipases segment accounted for $2,752.9 million in 2026 and is expected to boost at a CAGR of 9.8% during the forecast period; this is mainly because of its significant role in the water purification as well as the dairy industry

Specialty enzymes will generate significant market growth

On the basis of application, the global market is fragmented into industrial enzymes and specialty enzymes. The market size for specialty enzyme accounted for $9,295.4 million in 2026 and is projected to grow at a healthy CAGR of 10.5% during the period of forecast; this majorly because specialty enzymes have significant usage in chronic disease therapies such as lysosomal diseases and CVD’s (cardiovascular diseases).

Geographical Analysis and Major Market Players

On the basis of region, the global for enzyme market is classified into North America, Europe, Asia Pacific, and LAMEA. The Asia-Pacific Enzyme market valued at $4,647.7 million in 2026 and is anticipated to rise at 9.9% CAGR during the period of forecast. This is mainly because of the rapid expansion of food & beverages, detergent, and pharmaceutical industries significantly in South Korea, Japan, and Singapore.

The major players of the global enzyme market consist of BASF, Royal DSM, Enmex, Danisco A/S, Advanced Enzymes, Chr. Hansen, Lumis Biotech, Hayashibara, Aumgene Biosciences, and Codexis.

Contact Us:

Corona Impact: Is Coagulation Testing Market will Propel with its Advanced Approaches in 2020

The COVID-19 outbreak had a huge impact on the overall market for coagulation testing. The Instruments products type will be the most lucrative. The Asia-Pacific region will have good opportunities. The key players are developing strategies to achieve a competitive advantage in the industry.

As per the report by Research Dive, the global coagulation testing market is expected to reach up to $3,814.3 million by 2026, and to grow to 7.1% in the forecasted period between 2019 and 2026. COVID-19 outbreak has had a major impact on the coagulation testing market, and it is anticipated that there will be significant market growth. New research indicated that the main cause of deaths in COVID-19 patients with severe disease is coagulation dysfunctions. This coagulation dysfunction occurs primarily because of acute respiratory failure and coagulation of the blood (thrombosis).

Furthermore, in the COVID-19 outbreak period, many governments are taking various initiatives to support companies. The People’s Liberation Army Professional Committee of Critical Care Medicine and Chinese society, have come together to establish an expert consensus on coagulation dysfunction treatment and diagnosis related to a severe COVID-19 virus. In this time of crisis, these factors significantly drive market growth.

Highlights of the Report:

The global coagulation testing market has witnessed remarkable growth in the previous years. The sudden outbreak of coronavirus has impacted the market, bringing even more chances of growth. As per the report, the global coagulation testing market industry is expected to register a revenue of $3,814.3 million by 2026, at a growth rate of 7.1% during the forthcoming years. In the current situation, the market has garnered $2,555.1 million owing to the importance of coagulation testing therapies during the complete shutdown.

Factors Impacting the Market Growth amidst Covid-19 Pandemic

The benefits of coagulation testing, as well as the common use of coagulation testing treatments for hematology and thrombosis in hospitals and clinical laboratories, will drive the markets in the projected period. Conversely, the prohibitive cost of testing coagulation limits the market growth. Furthermore, the lack of skilled testing for coagulation and the use of analyzers could impede the industry’s growth.

Current Market Transformation Due to Covid-19:

– The current state of the market

The COVID-19 pandemic impacted the overall test-coagulation market positively. The analysis of a series of coagulation tests (PET) is carried out by researchers in the susceptibility tests of COVID-19 patients, such as platelet, fibrinogen, and dimer. There have been reports that patients with higher rates of D-dimers are more likely to face death. Many other government officials have taken a variety of steps to promote businesses during the pandemic. The Chinese government, for example, recently unveiled a new series of technical innovations to support new vertical business growth structures such as cloud, internet, industrial internet, and SOE technology. The government has decided to improve technology in the areas of telemedicine, life sciences, pharmaceutics, and pharmacy. However, the high costs associated with diagnosis and study should constrain market growth. Furthermore, the lack of qualified coagulation tests and the use of analyzers could also hamper industry growth.

Post-pandemic Market Insights:

As per the report, there are plans to maintain sustainable growth after the pandemic in the global coagulation test market. It is expected that in the coming few years, some of the leading market players will bring innovative progress and rewarding opportunities to the market. Some of these key players include Helena Laboratory Corporation, Thermo Fisher Scientific Inc., Micropoint Biosciences, F. Hoffmann La Roche Ltd, Medtronic, NIHON KOHDEN CORPORATION, Sysmex Corporation, Abbott and Danaher, among others.

Contact Us:

COVID-19 Impact Review: What Challenges Cancer Stem Cells Market May See In Next 5 Years?

The COVID-19 tragedy is expected to create a positive impact on the global cancer stem cells market. The bladder cancer segment is projected to grab major share of the market. The targeted cancerous stem cells segment is projected to observe significant growth. The Asia Pacific region is expected to lead the global market throughout the forecast period. The major players of the market are implementing several strategies to withstand their business amidst this catastrophic situation.

At this moment in time, the whole world is in havoc owing to the abrupt outburst of COVID-19 pandemic. However, this pandemic situation has created a positive impact on the global cancer stem cells market. A latest report published by Research Dive reveals that the global cancer stem cells market is anticipated to gather $1,898.3 billion by 2026, rising at a growth rate of 11.8% from 2019 to 2026. The report segments the global market into application, cancer forms, and region. The report provides comprehensive analysis of the impact of COVID-19 on the key drivers, opportunities, limitations, key segments, and top players of the global market.

Factors Impelling the Market Growth amidst COVID-19 Crisis

Regardless of the outbreak of COVID-19 pandemic, government bodies all over the world are hugely investing on research & development activities to enhance the use of cancer stem cells in the cancer treatments. Additionally, the development of stem cells for stem line banking and developing induced Pluri-Potent Stem Cell (PSC) lines is massively boosting the growth of the cancer stem cells market.

Bladder Cancer Segment to Seize Largest Share of the Market

Based on cancer forms, the report categorizes the global cancer stem cells market into brain, breast, bladder, liver, blood, pancreatic, lung, colorectal, and other. The bladder segment is dominating the market ever since 2018 and is predicted to gather $303.9 million by 2026. This segment is expected to grow majorly owing to the rising number of deaths due to bladder cancer, all over the world. According to the U.S. government, bladder cancer is the fifth most occurring cancer among all other types of cancer, and therefore it is optimistically influencing the global market growth throughout the projected period.

Targeted Cancerous Stem Cells Segment to Experience Considerable Growth

Based on application, the report divides the global market into targeted cancerous stem cells and stem cells-cancer therapy. Among these, the targeted cancerous stem cells segment is anticipated to observe significant growth at a CAGR of 13.0% throughout the projected period. As targeted cancerous stem cells have the ability to attract normal cells, they can be used positively to target cancer cells; this factor is greatly boosting the growth of this segment.

Regional Breakdown of the Market

Regionally, the report studies the market across North America, Asia-Pacific, Europe, and LAMEA. Among these, the Asia-Pacific region is anticipated to lead the global market by garnering $405.17 million by 2026. This is mostly due to the presence of considerable number of scientists in this region that are involved in R&D activities related to stem cell therapy.

Key Market Players

The prominent players in the global cancer stem cells market are Merck KGaA, AbbVie Inc., Irvine Scientific, Stem Cell Technologies Inc., MiltenyiBiotec, Thermo Fisher Scientific Inc., OncoMed Pharmaceuticals, Sino Biological Inc., BioTime Inc., and others. These market players are implementing various tactics to survive during this pandemic situation.

Contact Us:

Is Plasma Therapy Market Trapped Between Growth Expectations And Uncertainty?

The Covid-19 pandemic is anticipated to affect the worldwide computer aided drug discovery market positively. The respiratory disease therapeutic segment will generate a considerable amount of the global market share. The pharmaceutical end-user segment is anticipated to reach newer heights. The structure-based drug design segment is foreseen to overwhelm the global market share. The Asia-Pacific region will generate huge investment opportunities in the conjecturetime frame. The key players of the market are concentrating on various strategies to sustain in these trying times.

The sudden eruption of COVID-19 pandemic has imposed positive impact on the computer aided drug discovery market. Widespread coronavirus has influenced numerous medical organizations for the advancement of vaccines to treat infected persons around the world. According to a recent publication by Pharmaceutical Science and Computational Chemical Genomics Screening Centre, distinguishing proof of antibody or medication treatment for COVID-19 is studied using the computational drug repurposing method. This study has contributed to the development of vaccine for COVID-19 infection. Also besides, it stated that computer-aided drug design is an efficient procedure to contemplate the 3-dimensional structure of virus protein. Likewise, chloroquine phosphate is utilized for the treatment of COVID-19 infected persons. But according to publication made by Dr. Talluri Sekhar, this chloroquine is used to treat a few patients. Thus several studies are carried out to study the genomic structure and develop chloroquine with the help of computer-aided technology to utilize it on severely ill patients.

In addition, a team of Chinese scientists stated that the high-resolution crystal structure of the COVID-19 virus has been studied and developed an antiviral drug that can combat the virus. This protease structure was studied using virtual drug screening and structure-assist drug design. Thus these factors are driving the demand of the global computer aided drug discovery market in the forecast period of time. During this unique situation, our analysts are helping our clients in understanding the impact of COVID19 on the Computer aided drug discovery Market by providing them with an in-depth analysis.

As per a recent report published by Research Dive, the global computer aided drug discovery market is set to generate a revenue of $5,427.2 billion by 2026, at a CAGR of 16.9% during the forecast period from 2019 to 2026.

The global CADD market has been fragmented on the basis of type, therapeutic area, end-user and region. The computer aided drug discovery report provides in-depth insights on drivers, vital segments, opportunities, restraints, and key players of the market. As per our analysts, increased utilization of CADD method for various phase of drug development is expected to drive the global computer aided drug discovery market. However,it is difficult to copy and simulate the complete biological system on a computer system and flexibility are the factors restraining the market growth.

Structure-Based Drug Design Type to Have Dominant Share

Based on type, the global computer aided drug discovery market is classified into structure-based drug design (SBDD), ligand-based drug design (LBDD), and sequence-based approaches. The structure-based drug design segment represented $489.8 billion income in 2018 and is anticipated to develop at 17.3% CAGR by the end of 2026. This design is the developing iterative and ground-breaking approach for auxiliary assessment of drug discovery process and it is cost-effective method as compared to other design type.

Respiratory Disease Therapeutic Area to be Most Lucrative

In view oftherapeutic area, the global market for the computer aided drug discovery is segmented into oncology, neurology, cardiovascular disease, respiratory disease, diabetes and others. The market size for the respiratory disease accounted for $243.4 billion in 2018 and is estimated to grow with the highest CAGR of 17.3% CAGR by 2026. This development is attributed to the fast ascent in the respiratory issues due to growing prevalence for smoking and COVID-19 patients.

Pharmaceutical Companies to be Most Lucrative

On the basis of end-user, the computer aided drug discovery market is divided into pharmaceutical companies, biotechnology companies, research institutes and others. Pharmaceutical company segment is anticipated to dominate the global computer aided drug discovery market. Pharmaceutical company vertical accounted for $452.9 billion in 2018 and is projected to grow with a CAGR of 17.2% during the projected time frame. The growth is attributed due to the increasing demand for development of appropriate vaccine to treat COVID-19 patients around the world.

Geographical Analysis and Major Market Players

Based on the region, the global computer aided drug discovery market is segmented into North America, Europe, Asia Pacific, and LAMEA. The Asia-Pacific computer aided drug discovery market accounted for $411.3 billion in 2018 and is anticipated to rise at 17.6% CAGR throughout the forecast period. The growth is majorly attributed to the presence of major key-players in this region and their increasing investments for research & development activities to widen the utilization of CADD.

The major players of the global computer aided drug discovery market include BOC Sciences, BioDuro, Schrödinger, Aris Pharmaceuticals, Aragen Bioscience, Albany Molecular Research Inc. (AMRI), Charles River, AstraZeneca, Evotec A.G., and Bayers AG.

Contact Us:

How Computer Aided Drug Discovery Market Will Grow In Coming Future Despite COVID-19 Chaos?

The COVID-19 pandemic is anticipated to have a positive impact on the global plasma therapy market. The PRP segment is estimated to play a dominant role in the market during the forecast period. By source, the autologous segment is projected to witness a considerable growth by 2026. In addition, the Asia Pacific region is expected to create massive growth opportunities in the global market. Majority of the prominent players of the industry are adopting several strategies to strengthen their market position in these unprecedented times.

The global plasma therapy market is projected to garner $432.8 million by 2026, rising at a healthy CAGR of 16.3% from 2019 to 2026, reveals a new Research Dive published report. The report segments the global market into source, type, end-use, application, and region. The study offers comprehensive analysis of drivers, opportunities, restraints, vital segments, and top market players. As per the report, cumulative demand for plasma treatment for treating orthopedic conditions & neurological disorders and growing awareness amongst people regarding dental health & personalized healthcare systems are significant factors boosting the growth of the global plasma therapy market. Conversely, high expenses involved in plasma therapy is a prime factor predicted to restraint the market growth during the forecast period.

Growing Positively Despite COVID-19 Chaos

This sudden outburst of coronavirus pandemic has imposed an optimistic impact on the global plasma therapy market. This market is anticipated to observe significant growth during this pandemic period. Presently, scientists from various parts of the world are concentrating on numerous possibilities to invent an effective treatment or vaccine that can combat this life-threatening disease. Researchers are majorly considering the plasma therapy technique as a possible treatment for this disease. This factor is considerably boosting the demand for plasma therapy for the treatment of COVID-19 disease, thus boosting the market growth during the pandemic period.

PRP Segment to Play a Dominant Role in the Industry

By types, the global market for plasma therapy is divided into pure platelet-rich plasma (PRP), leukocyte-rich fibrin, leucocyte-rich PRP, and pure platelet-rich fibrin. Of these, the pure PRP segment accounted for $50.1 million in 2018 and is expected to rise at a healthy growth rate of 16.7% during the period of forecast. This growth is mainly attributed to the growing usage of pure PRP in the treatment of neurosurgery, orthopedics/spinal surgery, cosmetic surgery, and others due to its cost effectiveness than its other counterparts.

Autologous Source Segment to Lead the Market

Based on source, the global industry is classified into autologous and allogeneic. Among these, the autologous source segment is anticipated to reach up to $298.6 million by 2026. This segment is further expected to dominate the market throughout the forecast because autologous biologics plays a vital role in tissue repair and generation treatments and also helps in enhancing the healing power of recalcitrant and chronic wounds.

Regional Breakdown of the Market

Regionally, the report evaluates the global market across North America, Asia Pacific, Europe, and LAMEA. The North American region grabbed the majority of market share in 2018 and is expected to surpass $155.8 million revenue by 2026. This is primarily owing to the developments in advanced protein fractioning procedures and surging demand for plasma therapy techniques from hospitals & clinics in this region. Besides, the Asia-Pacific market for plasma therapy is projected to experience an impressive growth and generate rewarding growth opportunities during the estimated timeframe.

Major Market Players

The leading players functioning in the global plasma therapy market include Kedrion S.p.A, Grifols, S.A., CSL Limited, Cambryn Biologics, LLC, Bio Products Laboratory Ltd, Octapharma AG, BioLife PLASMA SERVICES, Biotest AG, China Biologic Products Holdings, Inc., and others. These players are involved into implementing several business ploys such as acquisitions, mergers, and collaborations & partnerships to obtain a major market share in the global industry.

Contact Us:

Home

Monday, August 16, 2021

Highlights of the Report:

Factors Driving the Market Growth amid COVID-19 Pandemic:

Current COVID-19 Impacted Scenario of the Market:

Future Scope of the Market:

Highlights of the Report

Implementing Several Strategies to Grow Exponentially Pandemic Crisis

Global Industry to Witness Impressive Growth Post-COVID-19 Chaos

Highlights of the Report

Sustaining in the Pandemic Situation

Global Industry to Witness Significant Growth Post-Coronavirus Chaos

Key Highlights of the Report:

Factors Boosting the Market Growth amidst Covid-19 Pandemic:

Current Market Situation Due to COVID-19:

Future Scope of the Market:

Highlights of the Report-

Key Features of the Market

Prominent Players of the Industry

Post-Pandemic Scenario

Highlights of the Report

Key Features of the Market

Prominent Players of the Industry

Post-Pandemic Scenario

Micro-organisms for the global enzyme market will have the fastest growth During 2020-27

Lipase will register substantial market growth during the period of forecast

Specialty enzymes will generate significant market growth

Geographical Analysis and Major Market Players

Highlights of the Report:

Factors Impacting the Market Growth amidst Covid-19 Pandemic

Current Market Transformation Due to Covid-19:

Post-pandemic Market Insights:

Factors Impelling the Market Growth amidst COVID-19 Crisis

Bladder Cancer Segment to Seize Largest Share of the Market

Targeted Cancerous Stem Cells Segment to Experience Considerable Growth

Regional Breakdown of the Market

Key Market Players

Structure-Based Drug Design Type to Have Dominant Share

Respiratory Disease Therapeutic Area to be Most Lucrative

Pharmaceutical Companies to be Most Lucrative

Geographical Analysis and Major Market Players

Growing Positively Despite COVID-19 Chaos

PRP Segment to Play a Dominant Role in the Industry

Autologous Source Segment to Lead the Market

Regional Breakdown of the Market

Major Market Players